An endometrial stromal sarcoma cell line with the JAZF1/PHF1 chimera
(2008) In Cancer Genetics and Cytogenetics 185(2). p.74-77- Abstract
Endometrial stromal sarcomas (ESS) are rare malignancies, accounting for less than 10% of uterine sarcomas. Apart from the chromosomal rearrangement t(7;17)(p15;q21), which leads to the JAZF1/SUZ12 chimera, cytogenetic studies have shown that the chromosome band 6p21 is often rearranged in ESS. The translocation partners involved in the 6p21 rearrangements differ among the tumors, but chromosome 7 is involved in most aberrations. A JAZF1/PHF1 fusion gene was recently found in two tumors showing an exchange between 6p and 7p rearrangement. In the present study, we show that a low-grade ESS cell line carrying a der(7)t(6;7)(p21;p22) also harbors the a JAZF1/PHF1 fusion. In the fusion transcript, exon 3 of JAZF1 was fused with exon 2 of... (More)
Endometrial stromal sarcomas (ESS) are rare malignancies, accounting for less than 10% of uterine sarcomas. Apart from the chromosomal rearrangement t(7;17)(p15;q21), which leads to the JAZF1/SUZ12 chimera, cytogenetic studies have shown that the chromosome band 6p21 is often rearranged in ESS. The translocation partners involved in the 6p21 rearrangements differ among the tumors, but chromosome 7 is involved in most aberrations. A JAZF1/PHF1 fusion gene was recently found in two tumors showing an exchange between 6p and 7p rearrangement. In the present study, we show that a low-grade ESS cell line carrying a der(7)t(6;7)(p21;p22) also harbors the a JAZF1/PHF1 fusion. In the fusion transcript, exon 3 of JAZF1 was fused with exon 2 of PHF1. At the junction, there was an insertion of 26 nucleotides, originating from intron 3 of JAZF1, thus maintaining an open reading frame of the chimeric transcript. The predicted 684-amino acid JAZF1/PHF1 chimeric protein retained one zinc finger domain from JAZF1 and the two zinc finger domains from PHF1, and its oncogenic mechanism should be similar to that of the JAZF1/SUZ12 protein. The present cell line constitutes an excellent model for further studies on the impact of the JAZF1/PHF1 fusion.
(Less)
- author
- Panagopoulos, Ioannis LU ; Mertens, Fredrik LU and Griffin, Constance A
- organization
- publishing date
- 2008-09
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Base Sequence, DNA Primers, DNA-Binding Proteins, Endometrial Neoplasms, Female, Humans, Karyotyping, Neoplasm Proteins, Recombinant Fusion Proteins, Reverse Transcriptase Polymerase Chain Reaction, Sarcoma, Stromal Cells, Transcription Factors, Journal Article, Research Support, Non-U.S. Gov't
- in
- Cancer Genetics and Cytogenetics
- volume
- 185
- issue
- 2
- pages
- 4 pages
- publisher
- Elsevier
- external identifiers
-
- wos:000259167700002
- pmid:18722875
- scopus:49649125809
- pmid:18722875
- ISSN
- 0165-4608
- DOI
- 10.1016/j.cancergencyto.2008.04.020
- language
- English
- LU publication?
- yes
- id
- 47650a4e-72ad-4d30-ab13-e13156f02332 (old id 1222975)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/18722875?dopt=Abstract
- date added to LUP
- 2016-04-04 09:28:46
- date last changed
- 2022-04-08 03:14:45
@article{47650a4e-72ad-4d30-ab13-e13156f02332, abstract = {{<p>Endometrial stromal sarcomas (ESS) are rare malignancies, accounting for less than 10% of uterine sarcomas. Apart from the chromosomal rearrangement t(7;17)(p15;q21), which leads to the JAZF1/SUZ12 chimera, cytogenetic studies have shown that the chromosome band 6p21 is often rearranged in ESS. The translocation partners involved in the 6p21 rearrangements differ among the tumors, but chromosome 7 is involved in most aberrations. A JAZF1/PHF1 fusion gene was recently found in two tumors showing an exchange between 6p and 7p rearrangement. In the present study, we show that a low-grade ESS cell line carrying a der(7)t(6;7)(p21;p22) also harbors the a JAZF1/PHF1 fusion. In the fusion transcript, exon 3 of JAZF1 was fused with exon 2 of PHF1. At the junction, there was an insertion of 26 nucleotides, originating from intron 3 of JAZF1, thus maintaining an open reading frame of the chimeric transcript. The predicted 684-amino acid JAZF1/PHF1 chimeric protein retained one zinc finger domain from JAZF1 and the two zinc finger domains from PHF1, and its oncogenic mechanism should be similar to that of the JAZF1/SUZ12 protein. The present cell line constitutes an excellent model for further studies on the impact of the JAZF1/PHF1 fusion.</p>}}, author = {{Panagopoulos, Ioannis and Mertens, Fredrik and Griffin, Constance A}}, issn = {{0165-4608}}, keywords = {{Base Sequence; DNA Primers; DNA-Binding Proteins; Endometrial Neoplasms; Female; Humans; Karyotyping; Neoplasm Proteins; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma; Stromal Cells; Transcription Factors; Journal Article; Research Support, Non-U.S. Gov't}}, language = {{eng}}, number = {{2}}, pages = {{74--77}}, publisher = {{Elsevier}}, series = {{Cancer Genetics and Cytogenetics}}, title = {{An endometrial stromal sarcoma cell line with the JAZF1/PHF1 chimera}}, url = {{http://dx.doi.org/10.1016/j.cancergencyto.2008.04.020}}, doi = {{10.1016/j.cancergencyto.2008.04.020}}, volume = {{185}}, year = {{2008}}, }